Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Chris Schott is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | LLY | Buy Now | Eli Lilly and Co | $953.00 | 4.93% | $900 → $1000 | Maintains | Overweight | Get Alert |
| 06/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | 6.27% | $1050 → $1150 | Maintains | Overweight | Get Alert |
| 05/01/2024 | LLY | Buy Now | Eli Lilly and Co | $953.00 | -5.56% | $850 → $900 | Maintains | Overweight | Get Alert |
| 04/11/2024 | BIIB | Buy Now | Biogen | $222.07 | 8.07% | $270 → $240 | Maintains | Neutral | Get Alert |
| 03/15/2024 | LLY | Buy Now | Eli Lilly and Co | $953.00 | -10.81% | $775 → $850 | Maintains | Overweight | Get Alert |
| 03/08/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.10 | -18.13% | → $14 | Upgrade | Underweight → Neutral | Get Alert |
| 02/28/2024 | PRGO | Buy Now | Perrigo | $26.90 | 52.42% | $48 → $41 | Maintains | Overweight | Get Alert |
| 02/20/2024 | RPRX | Buy Now | Royalty Pharma | $26.65 | 57.6% | $45 → $42 | Maintains | Overweight | Get Alert |
| 02/06/2024 | IDXX | Buy Now | IDEXX Laboratories | $482.70 | 30.52% | $600 → $630 | Maintains | Overweight | Get Alert |
| 11/08/2023 | LLY | Buy Now | Eli Lilly | $953.00 | — | — | Reiterates | → Overweight | Get Alert |
| 11/02/2023 | IDXX | Buy Now | IDEXX Laboratories | $482.70 | 13.94% | $600 → $550 | Maintains | Overweight | Get Alert |
| 10/20/2023 | AMGN | Buy Now | Amgen | $330.34 | -18.27% | → $270 | Reinstates | Neutral → Neutral | Get Alert |
| 10/16/2023 | PFE | Buy Now | Pfizer | $29.20 | 16.44% | $36 → $34 | Maintains | Neutral | Get Alert |
| 10/06/2023 | PFE | Buy Now | Pfizer | $29.20 | 23.29% | $39 → $36 | Maintains | Neutral | Get Alert |
| 08/09/2023 | PRGO | Buy Now | Perrigo | $26.90 | 78.44% | $45 → $48 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -37.04% | $510 → $600 | Maintains | Overweight | Get Alert |
| 08/02/2023 | IDXX | Buy Now | IDEXX Laboratories | $482.70 | 24.3% | $550 → $600 | Maintains | Overweight | Get Alert |
| 07/28/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -46.48% | $475 → $510 | Maintains | Overweight | Get Alert |
| 05/04/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -50.16% | $430 → $475 | Maintains | Overweight | Get Alert |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -54.88% | $400 → $430 | Maintains | Overweight | Get Alert |
| 03/31/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -12.21% | $900 → $950 | Maintains | Overweight | Get Alert |
| 02/23/2023 | MRK | Buy Now | Merck & Co | $128.30 | -2.57% | $120 → $125 | Maintains | Overweight | Get Alert |
| 02/07/2023 | IDXX | Buy Now | IDEXX Laboratories | $482.70 | 13.94% | $525 → $550 | Maintains | Overweight | Get Alert |
| 01/20/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -21.45% | → $850 | Upgrade | Neutral → Overweight | Get Alert |
| 11/15/2022 | VTRS | Buy Now | Viatris | $11.07 | 26.47% | $13 → $14 | Maintains | Neutral | Get Alert |
| 11/14/2022 | CHRS | Buy Now | Coherus BioSciences | $1.66 | 562.65% | $13 → $11 | Maintains | Neutral | Get Alert |
| 11/14/2022 | EQRX | Buy Now | EQRx | — | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/14/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.10 | -41.52% | $11 → $10 | Downgrade | Neutral → Underweight | Get Alert |
| 10/18/2022 | RPRX | Buy Now | Royalty Pharma | $26.65 | 95.12% | $50 → $52 | Maintains | Overweight | Get Alert |
| 10/17/2022 | ELAN | Buy Now | Elanco Animal Health | $13.79 | 45.03% | $24 → $20 | Maintains | Neutral | Get Alert |
| 10/17/2022 | HSKA | Buy Now | Heska | — | — | $175 → $150 | Maintains | Overweight | Get Alert |
| 10/17/2022 | ZTS | Buy Now | Zoetis | $177.98 | 26.42% | $250 → $225 | Maintains | Overweight | Get Alert |
| 10/17/2022 | IDXX | Buy Now | IDEXX Laboratories | $482.70 | -6.77% | $525 → $450 | Maintains | Overweight | Get Alert |
| 10/04/2022 | GILD | Buy Now | Gilead Sciences | $70.81 | 12.97% | $72 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 09/30/2022 | BIIB | Buy Now | Biogen | $222.07 | 23.83% | $221 → $275 | Maintains | Neutral | Get Alert |
| 08/16/2022 | EQRX | Buy Now | EQRx | — | — | → $5.5 | Initiates | → Neutral | Get Alert |
| 08/16/2022 | ELAN | Buy Now | Elanco Animal Health | $13.79 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2022 | BHC | Buy Now | Bausch Health Companies | $7.29 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/18/2022 | ELAN | Buy Now | Elanco Animal Health | $13.79 | 132.05% | $37 → $32 | Maintains | Overweight | Get Alert |
| 06/13/2022 | BHC | Buy Now | Bausch Health Companies | $7.29 | 64.61% | → $12 | Reinstates | → Overweight | Get Alert |
| 06/01/2022 | LLY | Buy Now | Eli Lilly | $953.00 | -62.75% | $340 → $355 | Maintains | Overweight | Get Alert |
| 04/14/2022 | RPRX | Buy Now | Royalty Pharma | $26.65 | 87.62% | → $50 | Upgrade | Neutral → Overweight | Get Alert |
| 03/07/2022 | CHRS | Buy Now | Coherus BioSciences | $1.66 | 803.61% | → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 02/23/2022 | HSKA | Buy Now | Heska | — | — | $300 → $250 | Maintains | Overweight | Get Alert |
| 01/28/2022 | MRK | Buy Now | Merck & Co | $128.30 | -25.95% | $100 → $95 | Maintains | Overweight | Get Alert |
